Benjamin Friedmann

Benjamin Friedmann is an accomplished professional in the field of oncology with extensive experience, currently serving as the Head of Lifecycle and Pipeline at AstraZeneca. With a strong academic background, Benjamin holds a First Class BSc(Hons) in Biochemistry from Imperial College London and a PhD in Medical Oncology from UCL. In addition to the role at AstraZeneca, Benjamin is an Honorary Senior Research Fellow at Imperial College London and has held leadership positions including Partner at Decision Resources Group and VP, Head of EMEA at Medisafe®, as well as VP, Oncology & Global Head of Therapy at SERMO.